News - 06 Feb `23Vitiligo Clinical Trials update

New

Vitiligo Clinical Trials update

Clinical trials are experiments that test how well new drugs, treatments or devices work in people. Trials progress through Phases I-IV to test a drug candidate, find the appropriate dosage, and look for side effects. The goal is to determine whether a medicine is both safe and effective. Drug candidates that have entered into clinical trials or pending approval by the U.S. Food and Drug Administration (FDA) are often said to be "in the pipeline." 

Our Trials Hub provides a comprehensive list of more than 20 active clinical trials located in Bangladesh, Canada, Egypt, France, Israel, and the United States.

👉 UPDATE February 6, 2023: New study posted "A Phase 1, Single and Multiple Ascending Dose (SAD/MAD) Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of VYN201 in Healthy Volunteers and in Subjects with Non-Segmental Vitiligo (NSV)" from Vyne Therapeutics.

Our CEO Yan Valle analyzes and monitors the entire drug development landscape along with the trends shaping and driving the vitiligo market, and reports findings in Vitiligo Drug Pipeline Analysis and Market Insights. 

 

Vitiligo clinical trials selector

 



      FAQOther Questions

      • Do Antioxidant Supplements Help Vitiligo?

        Do Antioxidant Supplements Help Vitiligo? Short answer Maybe a little. But probably not in the way most people hope. Antioxidant supplements may offer modest support, especially...

      • Awareness Days Similar to World Vitiligo Day

        World Vitiligo Day, celebrated annually on June 25 since 2012, is a significant event dedicated to raising awareness about vitiligo and supporting those affected by the conditio...

      • Will it spread?

        Vitiligo is famously unpredictable, but it doesn't move at random. By looking at thousands of cases, researchers have identified specific patterns of how the condition behaves. ...